Epidermal Growth Factor Upregulates Serotonin Transporter and Its Association with Visceral Hypersensitivity in Irritable Bowel Syndrome

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Oct 14

PMID 25309082

Citations 12

Authors

Xiu-Fang Cui

Wei-Mei Zhou

Yan Yang

Jun Zhou

Xue-Liang Li

Lin Lin

Hong-Jie Zhang

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the role of epidermal growth factor (EGF) in visceral hypersensitivity and its effect on the serotonin transporter (SERT).

Methods: A rat model for visceral hypersensitivity was established by intra-colonic infusion of 0.5% acetic acid in 10-d-old Sprague-Dawley rats. The visceral sensitivity was assessed by observing the abdominal withdrawal reflex and recording electromyographic activity of the external oblique muscle in response to colorectal distension. An enzyme-linked immunosorbent assay was used to measure the EGF levels in plasma and colonic tissues. SERT mRNA expression was detected by real-time PCR while protein level was determined by Western blot. The correlation between EGF and SERT levels in colon tissues was analyzed by Pearson's correlation analysis. SERT function was examined by tritiated serotonin (5-HT) uptake experiments. Rat intestinal epithelial cells (IEC-6) were used to examine the EGF regulatory effect on SERT expression and function via the EGF receptor (EGFR).

Results: EGF levels were significantly lower in the rats with visceral hypersensitivity as measured in plasma (2.639 ± 0.107 ng/mL vs 4.066 ± 0.573 ng/mL, P < 0.01) and in colonic tissue (3.244 ± 0.135 ng/100 mg vs 3.582 ± 0.197 ng/100 mg colon tissue, P < 0.01) compared with controls. Moreover, the EGF levels were positively correlated with SERT levels (r = 0.820, P < 0.01). EGF displayed dose- and time-dependent increased SERT gene expressions in IEC-6 cells. An EGFR kinase inhibitor inhibited the effect of EGF on SERT gene upregulation. SERT activity was enhanced following treatment with EGF (592.908 ± 31.515 fmol/min per milligram vs 316.789 ± 85.652 fmol/min per milligram protein, P < 0.05) and blocked by the EGFR kinase inhibitor in IEC-6 cells (590.274 ± 25.954 fmol/min per milligram vs 367.834 ± 120.307 fmol/min per milligram protein, P < 0.05).

Conclusion: A decrease in EGF levels may contribute to the formation of visceral hypersensitivity through downregulation of SERT-mediated 5-HT uptake into enterocytes.

Citing Articles

Research in revealing the effects on Cuscuta chinensis to diarrhea type irritable bowel syndrome based on network pharmacology and molecular docking potential mechanism.

Yang S, Liu H, Li K, Chen B, Tang Y, Li J Medicine (Baltimore). 2024; 103(19):e38113.

PMID: 38728495 PMC: 11081581. DOI: 10.1097/MD.0000000000038113.

Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model.

Leite G, de Freitas Germano J, Morales W, Weitsman S, Barlow G, Parodi G Gut Microbes. 2023; 16(1):2293170.

PMID: 38108386 PMC: 10730147. DOI: 10.1080/19490976.2023.2293170.

Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.

Santi M, Zhang M, Liu N, Viet C, Xie T, Jensen D Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004424 PMC: 10674507. DOI: 10.3390/ph16111558.

Exploring the Mechanisms of Self-made Kuiyu Pingchang Recipe for the Treatment of Ulcerative Colitis and Irritable Bowel Syndrome using a Network Pharmacology-based Approach and Molecular Docking.

Wen Y, Wang X, Si K, Xu L, Huang S, Zhan Y Curr Comput Aided Drug Des. 2023; 20(5):534-550.

PMID: 37190808 DOI: 10.2174/1573409919666230515103224.

Probiotics for the treatment of depression and its comorbidities: A systemic review.

Gao J, Zhao L, Cheng Y, Lei W, Wang Y, Liu X Front Cell Infect Microbiol. 2023; 13:1167116.

PMID: 37139495 PMC: 10149938. DOI: 10.3389/fcimb.2023.1167116.

References

Kekuda R, Leibach F, Ganapathy V . Human serotonin transporter: regulation by the neuroprotective agent aurintricarboxylic acid and by epidermal growth factor. J Neurochem. 1997; 68(4):1443-50. DOI: 10.1046/j.1471-4159.1997.68041443.x. View

Koldzic-Zivanovic N, Seitz P, Cunningham K, Thomas M, Hughes T . Serotonin regulation of serotonin uptake in RN46A cells. Cell Mol Neurobiol. 2006; 26(4-6):979-87. PMC: 11881821. DOI: 10.1007/s10571-006-9097-x. View

Riegler M, Sedivy R, Sogukoglu T, Cosentini E, Bischof G, Teleky B . Effect of growth factors on epithelial restitution of human colonic mucosa in vitro. Scand J Gastroenterol. 1997; 32(9):925-32. DOI: 10.3109/00365529709011204. View

Rao R . Biologically active peptides in the gastrointestinal lumen. Life Sci. 1991; 48(18):1685-704. DOI: 10.1016/0024-3205(91)90205-p. View

Kerckhoffs A, ter Linde J, Akkermans L, Samsom M . Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil. 2008; 20(8):900-7. DOI: 10.1111/j.1365-2982.2008.01100.x. View

Xu G, Shenoy M, Winston J, Mittal S, Pasricha P . P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut. 2008; 57(9):1230-7. DOI: 10.1136/gut.2007.134221. View

Coates M, Mahoney C, Linden D, Sampson J, Chen J, Blaszyk H . Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004; 126(7):1657-64. DOI: 10.1053/j.gastro.2004.03.013. View

Dunlop S, Coleman N, Blackshaw E, Perkins A, Singh G, Marsden C . Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005; 3(4):349-57. DOI: 10.1016/s1542-3565(04)00726-8. View

Latorre E, Mendoza C, Matheus N, Castro M, Grasa L, Mesonero J . IL-10 modulates serotonin transporter activity and molecular expression in intestinal epithelial cells. Cytokine. 2013; 61(3):778-84. DOI: 10.1016/j.cyto.2013.01.012. View

10.

Miwa J, Echizen H, Matsueda K, Umeda N . Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001; 63(3):188-94. DOI: 10.1159/000051888. View

11.

Dube P, Yan F, Punit S, Girish N, McElroy S, Washington M . Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest. 2012; 122(8):2780-92. PMC: 3408743. DOI: 10.1172/JCI62888. View

12.

Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha P . The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology. 2007; 132(2):615-27. DOI: 10.1053/j.gastro.2006.11.014. View

13.

Gordillo-Bastidas D, Oceguera-Contreras E, Salazar-Montes A, Gonzalez-Cuevas J, Hernandez-Ortega L, Armendariz-Borunda J . Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J Gastroenterol. 2014; 19(47):9020-33. PMC: 3870555. DOI: 10.3748/wjg.v19.i47.9020. View

14.

Martel F, Monteiro R, Lemos C . Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther. 2003; 306(1):355-62. DOI: 10.1124/jpet.103.049668. View

15.

Al-Chaer E, Kawasaki M, Pasricha P . A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology. 2000; 119(5):1276-85. DOI: 10.1053/gast.2000.19576. View

16.

Niederlechner S, Baird C, Petrie B, Wischmeyer E, Wischmeyer P . Epidermal growth factor receptor expression and signaling are essential in glutamine's cytoprotective mechanism in heat-stressed intestinal epithelial-6 cells. Am J Physiol Gastrointest Liver Physiol. 2013; 304(5):G543-52. PMC: 3602678. DOI: 10.1152/ajpgi.00418.2012. View

17.

Gendron F, Mongrain S, Laprise P, McMahon S, Dubois C, Blais M . The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am J Physiol Gastrointest Liver Physiol. 2005; 290(2):G310-8. DOI: 10.1152/ajpgi.00217.2005. View

18.

McCole D, Rogler G, Varki N, Barrett K . Epidermal growth factor partially restores colonic ion transport responses in mouse models of chronic colitis. Gastroenterology. 2005; 129(2):591-608. DOI: 10.1016/j.gastro.2005.06.004. View

19.

Kerckhoffs A, Ter Linde J, Akkermans L, Samsom M . SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol. 2012; 302(9):G1053-60. DOI: 10.1152/ajpgi.00153.2011. View

20.

Yan C, Xin-Guang L, Hua-Hong W, Jun-Xia L, Yi-Xuan L . Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats. Braz J Med Biol Res. 2012; 45(10):948-54. PMC: 3854181. DOI: 10.1590/s0100-879x2012007500122. View